Santen Pharmaceutical
4536.T
#3567
Rank
โ‚น380.89 B
Marketcap
โ‚น1,186
Share price
0.30%
Change (1 day)
34.82%
Change (1 year)

Revenue for Santen Pharmaceutical (4536.T)

Revenue in 2026 (TTM): โ‚น171.25 Billion

According to Santen Pharmaceutical 's latest financial reports the company's current revenue (TTM ) is โ‚น174.90 Billion. In 2025 the company made a revenue of โ‚น172.92 Billion an increase over the revenue in the year 2024 that were of โ‚น169.19 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Santen Pharmaceutical from 2009 to 2026

Annual revenue

Year Revenue Change
2026 (TTM) โ‚น171.25 B-0.97%
2025 โ‚น172.92 B2.21%
2024 โ‚น169.19 B-4.72%
2023 โ‚น177.57 B5.16%
2022 โ‚น168.85 B-3.54%
2021 โ‚น175.06 B5.2%
2020 โ‚น166.41 B4.69%
2019 โ‚น158.96 B9.18%
2018 โ‚น145.59 B17.93%
2017 โ‚น123.45 B-0.08%
2016 โ‚น123.55 B15.53%
2015 โ‚น106.94 B17.04%
2014 โ‚น91.37 B5.37%
2013 โ‚น86.71 B11.1%
2012 โ‚น78.05 B1.77%
2011 โ‚น76.69 B38.52%
2010 โ‚น55.36 B1.98%
2009 โ‚น54.29 B